Profound Medical Corp. Files 2024 Annual Report
Ticker: PROF · Form: 10-K · Filed: Mar 7, 2025 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 10-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials, medical-devices
TL;DR
Profound Medical Corp. 2024 10-K is in. Financials look steady, check RSU and APIC details for 2023/2024.
AI Summary
Profound Medical Corp. filed its 10-K for the fiscal year ending December 31, 2024. The filing details the company's financial performance and operations. Key financial data, including details on restricted stock units and additional paid-in capital for both 2023 and 2024, are presented.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Profound Medical Corp.'s financial health and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — As a medical device company, Profound Medical Corp. faces inherent risks related to regulatory approvals, market adoption, and competition, which are typical for the healthcare sector.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2023 — Prior Fiscal Year (Comparative financial data is presented for this year.)
Key Players & Entities
- Profound Medical Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-07 (date) — Filing date
- 2023-01-01 (date) — Start of fiscal year 2023
- 2024-01-01 (date) — Start of fiscal year 2024
FAQ
What is the primary business of Profound Medical Corp.?
Profound Medical Corp. operates in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was the company's name last changed?
The company's former name was Profound Medical Inc., and the date of the name change was December 22, 2014.
What is the company's principal executive office address?
The business and mailing address is 2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5.
What specific financial instruments are detailed in the filing for 2023 and 2024?
The filing details Restricted Stock Units (RSUs) and Deferred Stock Units (DSUs) in relation to Additional Paid-In Capital and Common Stock for the fiscal years 2023 and 2024.
What is the SEC file number for Profound Medical Corp.?
The SEC file number is 001-39032.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 7, 2025 regarding Profound Medical Corp. (PROF).